Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 15, 2017
Franklin Lakes, NJ (May 15, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming...
-
May 9, 2017BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room SettingNew Collaboration Aims to Provide Greater Visibility into Surgical Tracking and Loaner Tray Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and UniteOR, Inc., announced today the integration between BD's IMPRESS(TM) instrument management system...
-
May 7, 2017
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has commenced registered offerings of $2.25 billion of common stock, par value $1.00 per share, and $2.25 billion of...
-
May 7, 2017
FRANKLIN LAKES, N.J., May 7, 2017 - BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has commenced registered offerings of $2.25 billion of common stock, par value $1.00 per...
-
May 5, 2017
FRANKLIN LAKES, N.J., May 5, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that, in connection with BD's previously announced acquisition of C. R. Bard, Inc. ("Bard"), BD...
-
May 2, 2017
Click on the links below to view results for 2017 Second Fiscal Quarter: View Document Online PDF File of BD 2017 Second Fiscal Quarter Results About BD BD is one of the largest global medical...
-
May 2, 2017New Plastic Molding Manufacturing Center of Excellence Coming to Columbus-East Plant
COLUMBUS, Neb., May 2, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it will invest $60 million to upgrade its Columbus-East...
-
Apr 27, 2017Mass spectrometry identification solution may help hospitals manage antimicrobial resistance more effectively
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global distribution of a complete portfolio of products for mass spectrometry that...
-
Apr 26, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has non-exclusively licensed its patented stochastic labelling technology to...
-
Apr 23, 2017Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD’s Leadership Position in Medication Management and Infection Prevention; Will Increase Opportunities in Innovative Fast-Growing Clinical Areas Financially Compelling Transaction; Immediately Accretive and Expected to Generate High Single-Digit Accretion to Adjusted EPS in Fiscal Year 2019 Tom Polen Named BD President
FRANKLIN LAKES, NJ and MURRAY HILL, NJ (April 23, 2017) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and C. R. Bard, Inc. (NYSE: BCR), a medical...
-
Apr 23, 2017
FRANKLIN LAKES, N.J., April 23, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Tom Polen, 43, as president...
-
Apr 6, 2017BD FACSVia(TM) System for Clinical Simplicity in Cell Analysis and Enumeration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a...
-
Apr 6, 2017
FRANKLIN LAKES, N.J., April 6, 2017 – BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2017 earnings conference call...
-
Apr 4, 2017Expands Infusion Portfolio for Ambulatory, Home Care and Specialty Applications
FRANKLIN LAKES, N.J., April 4, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of...
-
Apr 3, 2017Visit booth #1115 to learn about the BD program focused on improving education, process and efficiency to impact patient safety
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its quality improvement program, BD "Power in Prevention" at the Association of...
-
Mar 28, 2017
WASHINGTON, March 28, 2017 – From the Mary’s Center in Washington, D.C., today BD (Becton, Dickinson and Company) (NYSE: BDX), in conjunction with Direct Relief and the National Association of...
-
Mar 22, 2017BD Showcases Solutions and Technologies to Improve Patient Safety Across the Continuum of Care at #EAHP2017
CANNES, March 22, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medication technology company, announced today the availability of its new IV Medication Safety Solution,...
-
Mar 1, 2017BD Awarded $100 Million Contract for Enterprise-Wide Automated Medication Dispensing Across 115 Military Health Facilities
FRANKLIN LAKES, N.J., MARCH 1, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it was awarded a contract worth up to $100...
Feb 22, 2017Health care providers and laboratories may be better equipped to test and treat patients during the flu seasonEffective Feb. 13, 2017, the Food and Drug Administration (FDA) has reclassified antigen based rapid influenza virus antigen detection systems (RIDTs) intended to detect influenza virus directly...
-
Feb 21, 2017BD Helping Build Healthy Communities(TM) Partnership Awarded for Helping Improve Care for Underserved Areas
A partnership among BD (Becton Dickinson and Company) (NYSE: BDX), Direct Relief and the National Association of Community Health Centers was selected as one of three winners for the Healthy10...
-
Feb 20, 2017BD Showcases its Leadership in Enterprise-wide Medication Management at #HIMSS2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate its approach to a synchronized medication management technology platform aimed to help...
-
Feb 17, 2017
Franklin Lakes, NJ (February 17, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming...
-
Feb 16, 2017BD Aims to Improve the Management of Controlled Substances for Acute Care Facilities through Industry Alliance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new alliance dedicated to help address the rising opioid crisis in acute care...
-
Feb 13, 2017Legacy Experience In Cell Sorting And Enrichment Combined With New Single- Cell And Library Prep Technology Offers Ideal Resolution Of Individual Cells At The Lowest Cost-Per-Answer
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an early access program for the BD Resolve(TM) Single-Cell Gene Expression platform...
-
Feb 2, 2017-- As reported, revenues of $2.922 billion decreased 2.1 percent, which reflects the divestiture of the Respiratory Solutions business.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.922 billion for the first fiscal quarter ended December 31,...
-
Feb 2, 2017Click on the links below to view results for 2017 First Fiscal Quarter:
View Document Online PDF File of BD 2017 First Fiscal Quarter Results About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by...
-
Jan 26, 2017BD Launches New Initiative to Drive Simpler, Safer and Cost-Effective Medication Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its new BD Institute for Medication Management Excellence, developed to...
-
Jan 23, 2017Indication for Congestive Heart Failure on Display at the 2017 Society of Thoracic Surgeons (STS) Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its PleurX(TM) catheter system received U.S. Food and Drug Administration (FDA) 510(k)...
-
Jan 23, 2017
Franklin Lakes, NJ (January 23, 2017) - The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 73 cents per common share, payable on March...
-
Jan 20, 2017New Framework Provides Recommendations for Optimizing Diagnostic Solutions to Combat AMR
Davos-Klosters, Switzerland - AdvaMedDx, the association representing manufacturers of diagnostic tests to promote wellness, improve patient outcomes, and advance public health, today announced a...
-
Jan 18, 2017
Franklin Lakes, NJ (January 18, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting...
-
Jan 17, 2017Precise WTA Reagents Provide Accurate, Simple Quantification of Genetic Information in Individual Cells
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of its new kits that provide an easier method to identify...
-
Jan 12, 2017Top 100 most innovative companies shift focus from quantity to quality
PHILADELPHIA, January 10, 2017 - Clarivate Analytics, formerly the Intellectual Property & Science business of Thomson Reuters, today announced its highly anticipated list of 2016 Top 100 Global...
-
Jan 11, 2017
Franklin Lakes, NJ (January 11, 2017) - Franklin Lakes, NJ (January 11, 2017) - BD(Becton, Dickinson and Company)(NYSE:BDX) announced today that it will conduct a live webcast of its first fiscal...
-
Jan 9, 2017
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the 35th Annual J. P. Morgan Healthcare Conference on Wednesday,...
-
Jan 9, 2017
Franklin Lakes, NJ (January 9, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the 35th Annual J. P....
-
Dec 19, 2016
Singapore, 19 December 2016 - SSON Analytics, the global data analytics centre of the Shared Services & Outsourcing Network (SSON), has today announced the launch of a new benchmarking study with...
-
Dec 15, 2016New BD Neopak(TM) 2.25 mL Prefillable Glass Syringe Helps Improve Safety and Convenience for Patients
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Neopak(TM) 2.25 mL prefillable glass syringe, specifically...
-
Dec 9, 2016
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) today issued the following statement to congratulate Dr. John Nkengasong on his appointment as the first director of the newly established...
-
Dec 5, 2016Experience the Difference of Enterprise-wide Medication Management at #ASHP16 Midyear Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate an enhanced technology platform designed with the ability to synchronize BD medication...
-
Dec 1, 2016New Operating System Offers Health Systems Long-Term Medication Management Platform and Enhanced Cybersecurity
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced adoption of Windows 10 Internet of Things (IoT) operating system (OS) for its...
-
Nov 17, 2016
Franklin Lakes, NJ (November 14, 2016) - BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will host an institutional investor and analyst meeting on Thursday, November 17,...
-
Nov 17, 2016
Earnings Releases / Presentations About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery,...
-
Nov 10, 2016BD to Showcase Latest Advancements at the 16th Annual Diabetes Technology Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company today announced a new research collaboration supported by JDRF, the leading global organization funding...
-
Nov 8, 2016BD and Lilly Diabetes Collaboration Offers New Delivery Solution for People with Insulin Resistance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company announced today the launch of the BD(TM) U-500 Insulin Syringe, the first insulin syringe developed for...
-
Nov 3, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Oct 31, 2016Expands Reproductive and Sexually Transmitted Infections Portfolio with First Test Using Microbiome-based Algorithm for Bacterial Vaginosis Detection
FRANKLIN LAKES, N.J., Oct. 31, 2016 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) market...
-
Oct 4, 2016Apax Funds to be majority owner of new company, Vyaire Medical
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Apax Partners, today announced the launch of a joint venture - Vyaire Medical - a standalone,...
-
Sep 30, 2016New BD Phoenix(TM) M50 System delivers modularity, reliability, affordability and high-quality susceptibility results needed by clinical microbiology laboratories worldwide
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation diagnostic instrument for the rapid identification of...
- Sep 29, 2016The New BD Vacutainer® Barricor(TM) Tube Offers First Major Advance in Plasma Separation Technology in Decades
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Vacutainer(®)...
-
Sep 22, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its...
- Sep 21, 2016New BD Veritor(TM) Plus System Enables Fast and Accurate Test Results for Health Care Providers
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of...
-
Sep 16, 2016BD ChloraShield(TM) Dressings are Now Available for a Range of Vascular Access Procedures
BD (Becton, Dickinson and Company) (NYSE: BDX) and Vancive Medical Technologies(TM), an Avery Dennison (NYSE: AVY) business, today launched a line of transparent vascular dressings with...
-
Sep 13, 2016BD Obtains FDA Clearance for the BD MAX CT/GC/TV Assay on the BD MAX™ System
FRANKLIN LAKES, N.J., Sept. 13, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained U.S. Food and Drug...
-
Sep 12, 2016Latest Release of Industry-Leading Pyxis ES platform Advances Enterprise-wide Medication Management and Patient Safety Across Continuum of Care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced general availability of the latest software release of Pyxis(TM) ES System, delivering...
-
Sep 6, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has submitted a pre-market approval (PMA) application to the U.S. Food and Drug...
-
Sep 1, 2016New Recommendations Based on Findings from Largest-Ever International Survey of more than 13,200 Insulin-Injecting Patients from 42 Countries
The prestigious medical journal, Mayo Clinic Proceedings , today published new insulin delivery recommendations for health care professionals caring for insulin-using patients, including the...
-
Aug 18, 2016Announces $20 Million Investment to Support Growth
SANDY, Utah, Aug. 18, 2016 /PRNewswire/ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined by senior public officials today to celebrate...
-
Aug 16, 2016Alaris(TM) System Also Cited as Most Comprehensive Infusion Platform
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Alaris(TM) System infusion platform was cited as having the most customers...
-
Aug 15, 2016
FRANKLIN LAKES, N.J., August 15, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug...
-
Aug 4, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 26, 2016 – The Board of Directors BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on September...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 28, 2016 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that R. Andrew “Andy” Eckert has been...
-
Jul 19, 2016More than 100 Hospitals Have Implemented Interoperability for Alaris(TM) System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that more than 100 hospitals and health systems have implemented the company's...
-
Jul 1, 2016
FRANKLIN LAKES, NJ July 1, 2016 – BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2016 earnings conference call on...
-
Jun 16, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a development and global distribution agreement with Check-Points for BD MAX(TM) assays...
-
May 26, 2016First Live Demonstration of the New Cell Sorter at Upcoming CYTO Annual Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, continues to reinforce its commitment to making flow cytometry easier and more affordable with the...
-
May 5, 2016
Click on the links below to view results for 2016 Second Fiscal Quarter: View document online » PDF File of BD 2016 Second Fiscal Quarter Results » About BD BD is one of the largest global...
-
Apr 26, 2016New BD U-40 Pet Syringes Available at Veterinary Offices
FRANKLIN LAKES, N.J., April 26, 2016 – BD (Becton, Dickinson and Company), a leading medical technology company, announced today that it has launched BD Pet Syringes – veterinary insulin...
-
Apr 22, 2016Genesis(TM) Low Temperature Rigid Sterilization Container System Validated for Modern Low-Temp Sterilization Practices
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new line of surgical instrument sterilization containers that are validated for the...
-
Apr 21, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which includes all AVAmax®,...
-
Mar 30, 2016
FRANKLIN LAKES, N.J., Mar. 30, 2016 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...
-
Mar 15, 2016Marks sixth year in top spot for infection control and monitoring category
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that BD MedMined(®) Surveillance Advisor has been named a 2015/2016 Category Leader for...
-
Mar 8, 2016Apax Funds will be majority owner of new company
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a definitive agreement to sell 50.1 percent of its Respiratory Solutions business to...
-
Mar 7, 2016Adds BD Totalys(TM) MultiProcessor and BD Totalys(TM) SlidePrep for Gynecological Specimen Preparation to Cytology Instrumentation Portfolio
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its BD Totalys(TM)...
-
Mar 6, 2016BD Vacutainer® Barricor™ Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time
FRANKLIN LAKES, N.J., March 1, 2016 – BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in Europe for a...
-
Mar 1, 2016
BD Vacutainer® Barricor(TM) Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time FRANKLIN LAKES, N.J., March 1, 2016 /PRNewswire/ -- BD...
-
Mar 1, 2016BD Exhibits Next Generation Wireless Diagnostic Test System at #HIMSS16
LAS VEGAS, March 1, 2016 –BD (Becton, Dickinson and Company), a leading global medical technology company, is utilizing AT&T* Internet of Things (IoT) services to connect wireless health...
-
Feb 24, 2016
FRANKLIN LAKES, N.J., Feb. 24, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Alaris™ System has been named 2015...
-
Feb 22, 2016
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: 2016 RBC...
-
Feb 17, 2016Novel PentaPoint(TM) Comfort and RightGauge(TM) Needle Technologies Help Improve Comfort, Access to Difficult Veins
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and European CE marking...
-
Feb 12, 2016BD CLiC(TM) System is the first, high-throughput, fully integrated, automated bench-top library preparation workflow
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD CLiC(TM) System during the 2016 Advances in Genome Biology and...
-
Feb 8, 2016Innovation Results from Collaboration with the National Institutes of Health
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony(TM) system, a novel cell analyzer enabling the...
-
Feb 5, 2016Revenue increased 16 percent to $1.07 billion
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its fiscal second quarter, growing revenue in every business line and major...
-
Feb 5, 2016Tests from DiabetOmics to be Integrated into BD Veritor™ Point-of-Care Diagnostic Platform
FRANKLIN LAKES, N.J., Feb. 5, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has entered into a licensing and distribution...
-
Feb 3, 2016
Click on the links below to view results for 2016 First Fiscal Quarter: View document online » PDF File of BD 2016 First Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Jan 25, 2016
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on March 31, 2016 to holders of record on March 10,...
-
Jan 21, 2016BD leverages Singularity University’s network of solution-shaping experts, faculty, development partners and a highly-engaged global community
MOUNTAIN VIEW, CA and FRANKLIN LAKES, NJ January 21, 2016 – Singularity University (SU), a benefit corporation focused on empowering leaders to leverage exponentially growing technologies to...
-
Jan 15, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 26,...
-
Jan 8, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Fresenius Kabi USA has acquired the BD Rx business, which includes a...
-
Jan 8, 2016
FRANKLIN LAKES, N.J. and LAKE ZURICH, Ill.,January 8, 2016 – Becton, Dickinson and Company (BD) (NYSE: BDX) and Fresenius Kabi USA announced today that Fresenius Kabi has acquired the BD Rx...
-
Jan 7, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2016 earnings conference call on Wednesday, February 3, 2016, at 8:00...
-
Jan 4, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 34th Annual J. P. Morgan Healthcare Conference on...
-
Dec 12, 2015State-of-the-Art Research System Optimized for Use with BD Horizon Brilliant(TM) Dyes Is Now Available Worldwide
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSCelesta(TM) flow cytometer during the 2015 American Society...
-
Dec 10, 2015
FRANKLIN LAKES, N.J., Dec. 10, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), today announced the U.S. Food and Drug Administration (FDA) has cleared two 510(k)s for its spine...
-
Dec 7, 2015Combined Technologies from BD, CareFusion Create End-to-End IV Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a simplified way for hospitals to manage intravenous (IV) medication to help improve...
-
Dec 2, 2015Visit the "BD Leadership Theater" to hear how health systems improve and advance quality and safety across the continuum of care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and CareFusion, a BD company, will present its combined, strengthened solutions together as one company,...
-
Nov 23, 2015
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.66 cents per common share, an increase of 10.0 percent from the previous quarter....
-
Nov 12, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Stifel 2015 Healthcare Conference Tuesday, November 17,...
-
Nov 7, 2015American Association for Respiratory Care (AARC) Presents Award at Annual Congress
TAMPA, Fla., Nov. 7, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), was presented today with the Zenith Award for the second year in a row from the American Association for Respiratory...
